The Big Picture: Is bigger really better?By Kathy Kincade, EditorWhen shopping for my Christmas tree last month, I encountered an annual dilemma: How big a tree did I want, and how much was I willing to pay for it?Fortunately, my son Tommy was
By Kathy Kincade, Editor
When shopping for my Christmas tree last month, I encountered an annual dilemma: How big a tree did I want, and how much was I willing to pay for it?
Fortunately, my son Tommy was along, and after close evaluation of several yucky trees, he pointed to a 7-foot blue spruce and pronounced it good. I tried not to cringe as I wrote out the $45 check; it was, after all, for a good cause. The small lot was sponsored by the local Boy Scouts.
I have to wonder if purchasing a PACS these days isnt much the same process. Vendors large and small were hawking their wares at the recent RSNA meeting, and after a while it was difficult to tell one system from another. In fact, the market has become so crowded and competitive that customers are increasingly turning to third parties to help them make their buying decisions.
With the industrys ongoing consolidation and growing activity from large information-systems firms, some market watchers believe that there will be less room for the startups and technology innovators that have helped spur this industry to the brink of success.
Not surprisingly, the smaller vendors I talked to at the RSNA meeting take issue with that viewpoint. Most report healthy sales as the technology migrates to the desktop and the market expands into smaller hospitals and clinics. With their nimble organizations and speed in bringing new technology to market, these firms believe they are better positioned than their larger counterparts to meet this growing demand.
Lets hope they are right. Too many choices may be overwhelming, but too few can hinder innovation and success.
© 2000 Miller Freeman, Inc., a United News & Media company.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.